029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
UBD812膀胱癌及膀胱组织组合芯片,附病理分级、TNM和临床分期,27例/81点
点 数81例 数27
行 数9列 数9
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:UBD812
 
膀胱癌及膀胱组织组合微阵列芯片,含15例膀胱癌(10例含有匹配癌旁),12例宫颈鳞状细胞癌(7例含有匹配癌旁),一例三点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Cer
-Cervix
Bla
-Bladder
 
AT (*)
 
Malignant (*)
 
Malignant (I)
 
Malignant (IB)
 
Malignant (IB1)
 
Malignant (II)
 
Malignant (IIA)
 
Malignant (IIIA)
 
Malignant (IIIB)
TISSUE  ARRAYS UBD812
1
2
3
4
5
6
7
8
9
A
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
B
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
C
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
D
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
E
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
F
CER
CER
CER
CER
CER
CER
CER
CER
CER
G
CER
CER
CER
CER
CER
CER
CER
CER
CER
H
CER
CER
CER
CER
CER
CER
CER
CER
CER
I
CER
CER
CER
CER
CER
CER
CER
CER
CER
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeisBackUp
A1137FBladderLow-grade urothelial carcinoma*T1N0M0IMalignantN
A2237FBladderLow-grade urothelial carcinoma*T1N0M0IMalignantN
A3337FBladderCancer adjacent bladder tissue***ATN
A4433MBladderHigh grade urothelial carcinoma with degenerate*T3N1M0IIIAMalignantN
A5533MBladderHigh grade urothelial carcinoma with degenerate*T3N1M0IIIAMalignantN
A6633MBladderCancer adjacent bladder tissue***ATN
A7773MBladderHigh grade urothelial carcinoma(9interstitial)*T3aN0M0IIIAMalignantN
A8873MBladderHigh grade urothelial carcinoma (interstitial)*T3aN0M0IIIAMalignantN
A9973MBladderCancer adjacent bladder tissue***ATN
B11053MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignantN
B21153MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignantN
B31253MBladderCancer adjacent bladder tissue***ATN
B41371MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignantN
B51471MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignantN
B61571MBladderCancer adjacent bladder tissue***ATN
B71651MBladderSquamous cell carcinoma2T2bN2M0IIIBMalignantN
B81751MBladderSquamous cell carcinoma2T2bN2M0IIIBMalignantN
B91851MBladderCancer adjacent bladder tissue***ATN
C11972MBladderSquamous cell carcinoma2--3T3bN0M0IIIAMalignantN
C22072MBladderSquamous cell carcinoma2--3T3bN0M0IIIAMalignantN
C32172MBladderCancer adjacent bladder tissue***ATN
C42252MBladderSquamous cell carcinoma3T3N0M0IIIAMalignantN
C52352MBladderSquamous cell carcinoma3T3N0M0IIIAMalignantN
C62452MBladderCancer adjacent bladder tissue***ATN
C72560MBladderSmall cell carcinoma*T2N1M0IIIAMalignantN
C82660MBladderSmall cell carcinoma*T2N1M0IIIAMalignantN
C92760MBladderCancer adjacent bladder tissue***ATN
D12850FBladderSmall cell carcinoma*T2N1M0IIIAMalignantN
D22950FBladderSmall cell carcinoma*T2N1M0IIIAMalignantN
D33050FBladderCancer adjacent bladder tissue***ATN
D43172MBladderLow-grade urothelial carcinoma*T1N0M0IMalignantN
D53272MBladderLow-grade urothelial carcinoma*T1N0M0IMalignantN
D63372MBladderLow-grade urothelial carcinoma*T1N0M0IMalignantN
D73445FBladderLow-grade urothelial carcinoma*T1N0M0IMalignantN
D83545FBladderLow-grade urothelial carcinoma*T1N0M0IMalignantN
D93645FBladderLow-grade urothelial carcinoma*T1N0M0IMalignantN
E13759FBladderLow-grade urothelial carcinoma*T1N0M0IMalignantN
E23859FBladderLow-grade urothelial carcinoma*T1N0M0IMalignantN
E33959FBladderLow-grade urothelial carcinoma*T1N0M0IMalignantN
E44061MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignantN
E54161MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignantN
E64261MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignantN
E74357FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignantN
E84457FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignantN
E94557FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignantN
F14637FCervixSquamous cell carcinoma2T1b1N0M0IB1MalignantN
F24737FCervixSquamous cell carcinoma2T1b1N0M0IB1MalignantN
F34837FCervixCancer adjacent cervix tissue***ATN
F44942FCervixSquamous cell carcinoma2T1b1N0M0IB1MalignantN
F55042FCervixSquamous cell carcinoma2T1b1N0M0IB1MalignantN
F65142FCervixCancer adjacent cervix tissue***ATN
F75248FCervixSquamous cell carcinoma2T1b1N0M0IB1MalignantN
F85348FCervixSquamous cell carcinoma with degenerate2T1b1N0M0IB1MalignantN
F95448FCervixCancer adjacent cervix tissue***ATN
G15540FCervixSquamous cell carcinoma2T1b1N0M0IB1MalignantN
G25640FCervixSquamous cell carcinoma2T1b1N0M0IB1MalignantN
G35740FCervixCancer adjacent cervix tissue***ATN
G45842FCervixSquamous cell carcinoma2T1b1N0M0IB1MalignantN
G55942FCervixSquamous cell carcinoma2T1b1N0M0IB1MalignantN
G66042FCervixCancer adjacent cervix tissue***ATN
G76148FCervixAdenosquamous carcinoma2--3**MalignantN
G86248FCervixAdenosquamous carcinoma2--3**MalignantN
G96348FCervixCancer adjacent cervix tissue***ATN
H16456FCervixSquamous cell carcinoma2--3T1b1N0M0IB1MalignantN
H26556FCervixSquamous cell carcinoma2--3T1b1N0M0IB1MalignantN
H36656FCervixCancer adjacent cervix tissue***ATN
H46746FCervixSquamous cell carcinoma2T1bN0M0IBMalignantN
H56846FCervixSquamous cell carcinoma2T1bN0M0IBMalignantN
H66946FCervixSquamous cell carcinoma2T1bN0M0IBMalignantN
H77044FCervixSquamous cell carcinoma2T1b1N0M0IB1MalignantN
H87144FCervixSquamous cell carcinoma2T1b1N0M0IB1MalignantN
H97244FCervixSquamous cell carcinoma2T1b1N0M0IB1MalignantN
I17339FCervixSquamous cell carcinoma2T1N0M0IMalignantN
I27439FCervixSquamous cell carcinoma2T1N0M0IMalignantN
I37539FCervixSquamous cell carcinoma2T1N0M0IMalignantN
I47624FCervixSquamous cell carcinoma2T2aN0M0IIAMalignantN
I57724FCervixSquamous cell carcinoma2T2aN0M0IIAMalignantN
I67824FCervixSquamous cell carcinoma2T2aN0M0IIAMalignantN
I77960FCervixSquamous cell carcinoma3T1N0M0IMalignantN
I88060FCervixSquamous cell carcinoma3T1N0M0IMalignantN
I98160FCervixSquamous cell carcinoma3T1N0M0IMalignantN
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情